Literature DB >> 32171581

One million screened: Scaling up SBIRT and buprenorphine treatment in hospital emergency departments across Maryland.

Laura B Monico1, Marla Oros2, Sadie Smith2, Shannon Gwin Mitchell3, Jan Gryczynski3, Robert Schwartz3.   

Abstract

PURPOSE: Identification of problematic alcohol use and substance use in the population has been a clinical challenge, especially during the heightened years of the opioid epidemic. Bringing Screening, Brief Intervention, and Referral to Treatment (SBIRT) to scale in medical settings, such as hospital emergency departments (EDs) could facilitate broad identification of substance use disorders, timely delivery of brief interventions, and successful linkages to treatment. PROCEDURES: This large-scale data analysis pulled electronic health record (EHR) data from 23 hospitals in the state of Maryland for over 1 million patient visits between July 2014 and November 2018.
FINDINGS: Of the 1,097,142 ED patients screened, 17.2% screened positive for problematic alcohol or any drug use in the previous 12 months. During this same period, 79,899 brief interventions were delivered, 15,961 referrals to outpatient treatment were made and 38.3% of those were successfully linked to treatment. Of the 950 patients exhibiting withdrawal symptoms, over two-thirds patients (70.1%; n = 666) were administered buprenorphine, 94.6% (n = 630) accepted a referral to buprenorphine treatment in the community, and 64.6% (n = 430) attended their first outpatient buprenorphine treatment visit. A total of 2382 patients presented to the ED with a suspected opioid overdose, over half were referred to the intervention program (53.8%) and 63.2% were successfully engaged by the PRCs in the ED.
CONCLUSIONS: This analysis supports the scalability of SBIRT in hospital EDs and presents an implementation model that can be replicated in EDs nationwide.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32171581     DOI: 10.1016/j.ajem.2020.03.005

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  5 in total

Review 1.  Emergency department-based efforts to offer medication treatment for opioid use disorder: What can we learn from current approaches?

Authors:  Maureen T Stewart; Neto Coulibaly; Daniel Schwartz; Judith Dey; Cindy Parks Thomas
Journal:  J Subst Abuse Treat       Date:  2021-05-15

2.  Universal screening for substance use by Peer Support Specialists in the Emergency Department is a pathway to buprenorphine treatment.

Authors:  Alex K Gertner; Kate E Roberts; Grayson Bowen; Brenda L Pearson; Robyn Jordan
Journal:  Addict Behav Rep       Date:  2021-09-25

3.  Retrospective analysis of patterns of opioid overdose and interventions delivered at a tertiary hospital emergency department: impact of COVID-19.

Authors:  Katherine L Potaka; Rebecca Freeman; Danny Soo; Nam-Anh Nguyen; Tin Fei Sim; Joanna C Moullin
Journal:  BMC Emerg Med       Date:  2022-04-09

4.  Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid.

Authors:  John C Messinger; Aaron S Kesselheim; Seanna M Vine; Michael A Fischer; Rachel E Barenie
Journal:  Subst Abuse       Date:  2022-09-29

5.  Compassion, stigma, and professionalism among emergency personnel responding to the opioid crisis: An exploratory study in New Hampshire, USA.

Authors:  Stephen A Metcalf; Elizabeth C Saunders; Sarah K Moore; Olivia Walsh; Andrea Meier; Samantha Auty; Sarah Y Bessen; Lisa A Marsch
Journal:  J Am Coll Emerg Physicians Open       Date:  2022-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.